カルナバイオサイエンス(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4572/E00987 | Carna Biosciences,Inc. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/10/21 | 日証協 | 241,759株 | -2.97% | 75,800株 | +83.57% | 915,959株 | -0.59% | 55,889株 | +1426.19% |
2022/10/14 | 日証協 | 249,159株 | -53.14% | 41,292株 | +5061.5% | 921,359株 | -1.06% | 3,662株 | -96.32% |
2022/10/07 | 日証協 | 531,759株 | +0.32% | 800株 | -97.93% | 931,259株 | -0.02% | 99,508株 | +27.73% |
2022/09/30 | 日証協 | 530,059株 | -31.52% | 38,692株 | -79.78% | 931,451株 | -15.88% | 77,905株 | -70.95% |
2022/09/22 | 日証協 | 774,056株 | +89.51% | 191,389株 | -46.3% | 1,107,248株 | +20.15% | 268,206株 | +84.37% |
2022/09/16 | 日証協 | 408,457株 | -0.58% | 356,390株 | +406.29% | 921,541株 | +0.46% | 145,472株 | +59.03% |
2022/09/09 | 日証協 | 410,859株 | -1.3% | 70,392株 | -50.94% | 917,341株 | +0.12% | 91,472株 | -5.01% |
2022/09/02 | 日証協 | 416,259株 | -1.51% | 143,484株 | -3.82% | 916,241株 | -0.09% | 96,298株 | +88.43% |
2022/08/26 | 日証協 | 422,659株 | -2.63% | 149,184株 | +99.2% | 917,041株 | -6.42% | 51,106株 | -58.41% |
2022/08/19 | 日証協 | 434,059株 | -2.65% | 74,892株 | +6141% | 979,941株 | -0.75% | 122,873株 | -0.76% |
2022/08/12 | 日証協 | 445,875株 | -0.93% | 1,200株 | -88.72% | 987,341株 | +0.53% | 123,809株 | +46.52% |
2022/08/05 | 日証協 | 450,075株 | +1.34% | 10,643株 | +2.34% | 982,141株 | +0.64% | 84,501株 | +87.8% |
2022/07/29 | 日証協 | 444,132株 | -11.23% | 10,400株 | -86.72% | 975,941株 | -1.92% | 44,995株 | -40.87% |
2022/07/22 | 日証協 | 500,332株 | -1.81% | 78,292株 | +24.84% | 995,041株 | -0.15% | 76,090株 | -38.68% |
2022/07/15 | 日証協 | 509,532株 | +18.49% | 62,716株 | 0% | 996,541株 | +0.67% | 124,085株 | +72.84% |
2022/07/08 | 日証協 | 430,032株 | -0.21% | 0株 | -100% | 989,941株 | -0.04% | 71,791株 | -48.46% |
2022/07/01 | 日証協 | 430,932株 | -3.39% | 19,100株 | -81.16% | 990,340株 | -1.22% | 139,280株 | +1.09% |
2022/06/24 | 日証協 | 446,032株 | 0% | 101,400株 | 0% | 1,002,541株 | -0.04% | 137,781株 | +37.81% |
2022/06/17 | 日証協 | 446,032株 | -3.21% | 0株 | -100% | 1,002,935株 | -1.26% | 99,980株 | -39.69% |
※株式分割は考慮していませんのでご注意ください。
Page Top